• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过测序与TCGA数据库的综合分析鉴定中枢神经系统弥漫性大B细胞淋巴瘤(DLBCL)中的关键突变

Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database.

作者信息

Zhou Chunhui, Cui Yong, Sun Haomin, Yang Fan, Zhao Hao, Huangfu Luokai, Zhang Jianning

机构信息

Medical School of Chinese PLA, Beijing, China.

Department of Neurosurgery, PLA General Hospital, Beijing, China.

出版信息

Transl Cancer Res. 2021 Jun;10(6):2632-2642. doi: 10.21037/tcr-20-2525.

DOI:10.21037/tcr-20-2525
PMID:35116576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8799296/
Abstract

BACKGROUND

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma, and hence, a comprehensive understanding based on the gene expression profile is imperative. Although several studies have identified some critical mutant genes of DLBCL, the disease in the central nervous system has not been investigated clearly. This study is aimed to identify some novel and important mutant genes of DLBCL in central nervous system.

METHODS

A total of 156 cases of central nervous tumors were collected from 2016 to 2018, in which the DLBCL cases were confirmed by H&E staining and immunohistochemistry. With the whole-genome high-throughput sequencing, the mutations of samples were identified. By matching with TCGA database, the common mutations of DLBCL were further confirmed.

RESULTS

Twelve cases were designated as DLBCL, of which 1 case was classified into germinal center B cell (GCB) subtype, and 11 cases were non-GCB subtypes. The gene mutation spectrum demonstrated that the most common substitutions of six single bases were C>T/G>A, wherein the mutation frequency of C(C>T) G was the highest. The most common type of mutation is missense, and the most frequently mutated genes included , , , and . Based on the TCGA database, finally, the 4 significantly mutated genes (SMG), including , , , and common in the above groups, were identified.

CONCLUSIONS

Taken together, the analysis of the TCGA database and the results of the sequencing experiment displayed four mutations that might provide novel targets for the treatment of DLBCL.

摘要

背景

弥漫性大B细胞淋巴瘤(DLBCL)是最常见的非霍奇金淋巴瘤类型,因此,基于基因表达谱进行全面了解势在必行。尽管多项研究已鉴定出DLBCL的一些关键突变基因,但中枢神经系统中的该疾病尚未得到明确研究。本研究旨在鉴定中枢神经系统中DLBCL的一些新的重要突变基因。

方法

2016年至2018年共收集156例中枢神经肿瘤病例,其中DLBCL病例经苏木精-伊红染色和免疫组织化学确诊。通过全基因组高通量测序鉴定样本中的突变。通过与TCGA数据库匹配,进一步确认DLBCL的常见突变。

结果

12例被诊断为DLBCL,其中1例为生发中心B细胞(GCB)亚型,11例为非GCB亚型。基因突变谱显示,六个单碱基最常见的替换是C>T/G>A,其中C(C>T)G的突变频率最高。最常见的突变类型是错义突变,最常发生突变的基因包括 、 、 、 和 。最后,基于TCGA数据库,确定了上述组中共同存在的4个显著突变基因(SMG),包括 、 、 和 。

结论

综合来看,TCGA数据库分析和测序实验结果显示了四个突变,可能为DLBCL的治疗提供新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/c1760e1a653e/tcr-10-06-2632-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/62cc5bd3a2f5/tcr-10-06-2632-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/8e71507e700e/tcr-10-06-2632-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/1e2ebc1c8bd8/tcr-10-06-2632-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/c1760e1a653e/tcr-10-06-2632-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/62cc5bd3a2f5/tcr-10-06-2632-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/8e71507e700e/tcr-10-06-2632-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/1e2ebc1c8bd8/tcr-10-06-2632-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a4/8799296/c1760e1a653e/tcr-10-06-2632-f4.jpg

相似文献

1
Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database.通过测序与TCGA数据库的综合分析鉴定中枢神经系统弥漫性大B细胞淋巴瘤(DLBCL)中的关键突变
Transl Cancer Res. 2021 Jun;10(6):2632-2642. doi: 10.21037/tcr-20-2525.
2
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.中枢神经系统原发性弥漫性大 B 细胞淋巴瘤的基因组分析提示了新的潜在治疗靶点。
Mod Pathol. 2023 Dec;36(12):100323. doi: 10.1016/j.modpat.2023.100323. Epub 2023 Sep 9.
3
Prevalence And Clinical Significance Of Oncogenic And Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China.原发性睾丸弥漫性大B细胞淋巴瘤中致癌基因及突变的患病率和临床意义:一项中国的回顾性研究
Onco Targets Ther. 2019 Nov 26;12:10165-10175. doi: 10.2147/OTT.S222189. eCollection 2019.
4
MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.MYD88、CARD11和CD79B致癌突变在印度初发性淋巴结弥漫性大B细胞淋巴瘤队列中是罕见事件。
Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):311-318. doi: 10.1097/PAI.0000000000000585.
5
Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.原发性中枢神经系统弥漫性大B细胞淋巴瘤中MYD88和CD79B突变频率以及MGMT甲基化情况
Neuropathology. 2017 Dec;37(6):509-516. doi: 10.1111/neup.12405. Epub 2017 Aug 30.
6
MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.CD5阳性弥漫性大B细胞淋巴瘤中的MYD88、CD79B和CARD11基因突变
Cancer. 2017 Apr 1;123(7):1166-1173. doi: 10.1002/cncr.30404. Epub 2016 Dec 4.
7
Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.在生发中心 B 细胞型(GCB)和活化 B 细胞型(ABC)弥漫性大 B 细胞淋巴瘤中,靶向激活突变非常常见。
Genes Chromosomes Cancer. 2014 Feb;53(2):144-53. doi: 10.1002/gcc.22126. Epub 2013 Nov 5.
8
Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.原发性乳腺弥漫性大B细胞淋巴瘤中频繁出现的MYD88 L265P和CD79B突变
Am J Surg Pathol. 2016 Mar;40(3):324-34. doi: 10.1097/PAS.0000000000000592.
9
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤的分子发病机制
J Clin Exp Hematop. 2016;56(2):71-78. doi: 10.3960/jslrt.56.71.
10
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.原发性胃肠道弥漫性大B细胞淋巴瘤的基因组突变谱
Front Oncol. 2021 Mar 5;11:622648. doi: 10.3389/fonc.2021.622648. eCollection 2021.

引用本文的文献

1
Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中5-甲基胞嘧啶相关基因的鉴定与验证
Heliyon. 2023 Nov 10;9(11):e22209. doi: 10.1016/j.heliyon.2023.e22209. eCollection 2023 Nov.
2
Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.基线C反应蛋白在弥漫性大B细胞淋巴瘤中的预后价值:一项系统评价和荟萃分析。
Transl Cancer Res. 2023 Aug 31;12(8):2169-2180. doi: 10.21037/tcr-23-1157. Epub 2023 Aug 23.

本文引用的文献

1
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.具有治疗意义的弥漫性大 B 细胞淋巴瘤遗传亚型的概率分类工具。
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
2
Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.长链非编码 RNA SNHG16 通过靶向 miR-497-5p/PIM1 轴促进弥漫性大 B 细胞淋巴瘤细胞的增殖并抑制其凋亡。
J Cell Mol Med. 2019 Nov;23(11):7395-7405. doi: 10.1111/jcmm.14601. Epub 2019 Sep 4.
3
High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation.
高通量测序鉴定乳腺癌分泌的外泌体 LncRNAs 引发肺前转移龛形成。
Gene. 2019 Aug 20;710:258-264. doi: 10.1016/j.gene.2019.06.004. Epub 2019 Jun 7.
4
Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma.初发CD5+弥漫性大B细胞淋巴瘤的临床病理意义及治疗启示
Hematology. 2019 Dec;24(1):446-454. doi: 10.1080/16078454.2019.1614289.
5
Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤中 TP53 基因失活的临床方面。
BMC Med Genomics. 2019 Mar 13;12(Suppl 2):35. doi: 10.1186/s12920-019-0484-9.
6
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.将起源细胞纳入临床中枢神经系统国际预后指数可改善弥漫性大 B 细胞淋巴瘤中枢神经系统复发的预测。
Blood. 2019 Feb 28;133(9):919-926. doi: 10.1182/blood-2018-07-862862. Epub 2019 Jan 7.
7
Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease.原发性中枢神经系统淋巴瘤患者来源的原位异种移植模型捕捉了该疾病的生物学和分子特征。
Blood Cells Mol Dis. 2019 Mar;75:1-10. doi: 10.1016/j.bcmd.2018.11.005. Epub 2018 Nov 16.
8
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.淋巴瘤中的致癌性 MYD88 突变:新的见解和治疗可能性。
Cancer Immunol Immunother. 2018 Nov;67(11):1797-1807. doi: 10.1007/s00262-018-2242-9. Epub 2018 Sep 11.
9
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.作者更正:弥漫性大B细胞淋巴瘤的分子亚型与不同的致病机制和预后相关。
Nat Med. 2018 Aug;24(8):1290-1291. doi: 10.1038/s41591-018-0097-4.
10
High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.高通量测序筛选前列腺癌风险单核苷酸多态性。
Nat Commun. 2018 May 22;9(1):2022. doi: 10.1038/s41467-018-04451-x.